NOTE

🌱 created from: workup_of_mantle_cell_lymphoma

tp53_sequencing_in_mantle_cell_lymphoma

• TP53 mutation has been associated with poor prognosis in patients treated with conventional therapy, including transplant.
• Clinical trial is strongly recommended for these patients.
• TP53 sequencing is preferred; however, in the front-line setting, TP53 by IHC can be used as a surrogate but should be
  • confirmed with sequencing.
  • NGS?